Navigation Links
BioMedical Enterprises, Inc. (BME) Introduces the HammerLock™ Shape Memory Device for Hammertoes.
Date:10/18/2010

SAN ANTONIO, Oct. 18 /PRNewswire/ -- BioMedical Enterprises, Inc. (BME), a privately held medical device company and leader in orthopedic shape memory implant technology, announces the nationwide launch of the HammerLock™ Intramedullary Nitinol Fixation System for use in the correction of hammertoes.  

A hammertoe is a permanent and sometimes painful deformity of the proximal joint of the 2nd through 5th toes.  Hundreds of thousands of people seek treatment each year for this condition and surgical intervention is often necessary to bring relief to the patient.  The most common correction method involves the use of a thin wire to stabilize the joint.  This method, which leaves the wire exposed for several weeks, results in complications and is an inconvenience for the patient.  

The BME HammerLock™ stabilizes the proximal joint of the toe without the need for exposed wires. Formed out of the biocompatible shape memory alloy Nitinol, the HammerLock™ is designed to change shape when exposed to body heat.  After being placed internally across the joint in its closed, spear-like shape, the implant morphs as it warms to normal limb temperature to provide strong fixation of the proximal joint of the toe.  Its spring-like behavior then compresses the joint long-term resulting in an optimal environment for healing.  

Made by Texas-based BME, the only Nitinol small bone fixation manufacturer in the U.S., the HammerLock™ was carefully designed with the feedback of dozens of foot surgeons from across the country resulting in an advanced, robust implant that provides secure fixation.  In addition, the implant's patent-pending storage and deployment system sets a new standard for quick, simple and precise insertion minimizing operating room time.  

"The new BME HammerLock™ intramedullary implant has improved my patient outcomes for hammertoe surgery," says Dr. Jeremy McVay.  "It is easy to implant and comes in a variety of sizes to better suit each patient.  The superior design provides better compressive capabilities compared to others on the market."

Mr. Keith M Peeples, President and CEO of BME stated, "Patients and surgeons have asked for another new intramedullary device for the treatment of hammertoes and the BME HammerLock™ has proven to be an excellent next step.  This is the first of many new products being delivered from the BME drawing board."

BioMedical Enterprises, Inc., (BME) originally founded as a biomedical research firm specializing in bone healing, is now a reconstructive bone fusion product company and the worldwide leader in the understanding of memory metal and its orthopedic applications.  BME was the first company to introduce above body temperature shape changing memory metal staples to the U.S., the first to develop and patent a method of controlling their compressive forces and the only U.S.-based memory metal small bone implant manufacturer.  For more information, visit www.bmeortho.com.


'/>"/>
SOURCE BioMedical Enterprises, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston University Biomedical Engineers Find Chink in Bacterias Armor
2. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
3. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
4. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
5. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
6. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
7. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
8. Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary, Sanvita, Inc.
9. Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research
10. Volcano Corporation Completes Acquisition of Lumen Biomedicals Xtract(TM) Thrombus Aspiration Catheter
11. Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... and Markets has announced the addition of the "Contraceptives - Global ... ... US, Canada , Japan , ... America , and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:2/17/2017)... Feb. 17, 2017  Ethicon, Inc. today announced ... a privately held medical device company that manufactures ... System, a novel minimally invasive device for the ... Medical will enable Ethicon to offer patients a ... Nissen fundoplication surgical procedure. 1 ...
(Date:2/17/2017)... Theravance Biopharma, Inc. (NASDAQ: ... announced the presentation of positive clinical data for ... kinase (JAK) inhibitor designed to be intestinally restricted, ... European Crohn,s and Colitis Organization (ECCO). In a ... its completed Phase 1 study of single-ascending and ...
Breaking Medicine Technology:
(Date:2/17/2017)... CA (PRWEB) , ... February 17, 2017 , ... ... that their Chief Executive Officer, George Rogers, was named to Staffing Industry Analysts' ... The Staffing 100 honors those who have made notable contributions to the staffing ...
(Date:2/17/2017)... ... , ... Like most hospitals across the nation, Onslow Memorial Hospital is looking ... Readmission Reduction Program (HRRP), the return of a patient to the hospital within 30 ... While many providers are struggling to leverage limited resources and technology, Onslow Memorial Hospital ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason ... to families and business owners in and around the Hampton Roads metropolitan region, ... prevent all forms of domestic violence. , There are multiple categories of domestic ...
(Date:2/16/2017)... ... February 17, 2017 , ... Harsha Chigurupati knows ... of research, development and clinical trials, the founder of Chigurupati Technologies has invented ... of FDA approved ingredients that when infused into alcohol, protect the consumer’s liver ...
(Date:2/16/2017)... ... 17, 2017 , ... Teaching nursing care of vulnerable children is the focus ... is being created with the support of the Hearst Foundations. An initiative of the ... address what has been identified as a critical gap in preparing the next generation ...
Breaking Medicine News(10 mins):